Galderma India promotes Ashish Ghosh to business unit head of Therapeutic Dermatology

MUMBAI: Galderma India has promoted Ashish Ghosh as Business Unit Head, Therapeutic Dermatology, reinforcing its focus on leadership depth as the Swiss dermatology giant scales its prescription-led offerings in the country.

The Therapeutic Dermatology (TD) business, representing Galderma’s prescription portfolio, plays a pivotal role in advancing dermatological solutions through healthcare practitioners.

A homegrown talent, Ghosh has spent over a decade at Galderma, starting in a front-line role and steadily taking on greater responsibility. He has led sales and marketing strategy for the TD business, gaining deep on-ground and commercial insight into the category. Under his leadership, the unit has consistently delivered blockbuster performance, cementing Galderma’s position in prescription dermatology.

In his new role, Ghosh will focus on accelerating growth momentum and strengthening market leadership across the prescription portfolio. “Each role across different cities and challenges has shaped me professionally and personally. At Galderma, the freedom to explore, take ownership and lead from any seat has been a key driver of my development,” said Ghosh.

As Galderma expands in India, the company remains committed to investing in internal talent, fostering innovation-led leadership, and driving sustainable, long-term growth across its dermatology portfolio. With Ashish at the helm, the TD business is set to scale new heights and consolidate its market dominance.